TCTR20190806005尚未招募4 期
Bioequivalence study of tadalafil 5 mg film-coated tablet in Thai healthy volunteers
Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 60 人开始时间: 2019年8月6日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Years 至 50 Years（—）
- 性别
- Male
入选标准
- •1. Subjects who are Thai male, aged 18 to 50 years (inclusive).
- •2. Subjects whose BMI is 18.0-25.0 kg/m2 (inclusive).
- •3. Subjects who are healthy by medical history, physical examination, vital signs and EKG.
- •4. Subject whose screening visit laboratory values of blood tests including complete blood count, fasting blood sugar, blood urea nitrogen, serum creatinine, alkaline phosphatase, ALT, AST, total bilirubin, albumin are within the normal range or showing no clinically significant abnormalities as confirmed by the clinical investigator. HBsAg is negative.
- •5. Subjects are able to understand the requirements of the study and voluntarily sign and date an informed consent, approved by the Independent Ethic Committee (IEC)/ Institutional Review Board (IRB), prior to the initiation of any screening or study-specific procedures
- •6. Alcohol breath test is negative.
排除标准
- •1. Subjects who are with a history/evidence of drug sensitivity or allergic reaction to tadalafil, or any related drug.
- •2. Subjects who have a history of any illness that, in the opinion of the clinical investigator, might confound the result of the study or pose an additional risk in administrating study drug to the subjects.
- •3. Subjects who have significant of abnormal EKG (depend on clinical investigator decision).
- •4. Subjects who are with a history of heavy smoking (more than 10 cigarettes per day) or moderate smoking (less than 10 cigarettes per day) and cannot omit smoking at least three days before the study and until the completion of the study period.
- •5. Subjects who are with a history of alcoholic (more than 2 years) or for men, more than 4 drinks on any single day and more than 14 drinks per week.
- •6. Subjects who are with a history of any drug abuse. eg. Morphine, methamphetamine, tetrahydrocannabinol (marijuana).
- •7. Subjects who receive of any medical prescription, herbal medicine and food supplement within 14 days before the first administration of the study drug, especially drug related to the study drug metabolizing enzyme.
- •8. Subjects who are participating in any investigational drug study or had been in any investigational drug study within 3 months prior to the screening visit.
研究者
相似试验
招募中
不适用
Investigating the in vivo bioequivalence of Tadalafil 5 mg tabletIn the present study, the products will be administered to healthy volunteers..IRCT20210519051345N22Tabriz University of Medical Sciences24
招募中
不适用
In-vivo Bioequivalence study of Tadalafil tablet with brand drugs (CIALIS Lilly USA)IRCT20200105046010N39Mofid Pharmaceutical Co.24
已完成
不适用
The effect of tadalafil compared to tamsulosin and placebo on the symptoms of double-J stent insertion in men with ureter stonesCondition 1: Lower urinary tract symptoms. Condition 2: Pain in the flank and suprapubic areas. Condition 3: Sexual function.Calculus of lower urinary tractOther and unspecified abdominal painUnspecified sexual dysfunction, not caused by organic disorder or diseaseIRCT201702261853N13rology Research Centre, Guilan University of Medical Sciences120
进行中（未招募）
4 期
The effect of tadalafil in the treatment of erectile dysfunction in patients with chronic renal failureerectile dysfunctionend stage renal diseasehaemodialysiskidney transplantRenal DialysisKidney TransplantationErectile DysfunctionKidney Failure, ChronicTCTR20220310008rology-Nephrology Research Center of Shahid Beheshti University of Medical Sciences45
尚未招募
4 期
A study to compare the beneficial effect and safety of tadalafil compared to sildenafil in pulmonary hypertensive patients due to lung diseaseCTRI/2024/06/069470Midhun Sakravarthy J